Christopher James, DO
Psychosomatic Medicine · Willoughby, OHNPI 1790996726
Payments from drug & device makers
Across 179 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$527
- Lundbeck LLC$385
- Johnson & Johnson$358
- Takeda Pharmaceuticals U.S.A., Inc.$297
- Otsuka America Pharmaceutical, Inc.$265
- Vanda Pharmaceuticals Inc.$168
- plus $889 from 16 others
What the payments were for
- Food & beverage$2,85499%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $527 |
| Lundbeck LLC | 24 | $385 |
| Johnson & Johnson | 15 | $358 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $297 |
| Otsuka America Pharmaceutical, Inc. | 15 | $265 |
| Vanda Pharmaceuticals Inc. | 9 | $168 |
| Alkermes, Inc. | 7 | $140 |
| Sunovion Pharmaceuticals Inc. | 9 | $125 |
| Shire North American Group Inc | 6 | $119 |
| Neos Therapeutics, LP | 7 | $109 |
| Bausch Health US, LLC | 4 | $75 |
| Corium, LLC | 3 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $40 |
| Tris Pharma Inc | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 2 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $16 |
| Neuronetics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$122
How this compares
Too few psychosomatic medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 24 | $34,138 |
| TrintellixVortioxetine Hydrobromide | 26 | $16,981 |
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,637 |
| Lurasidone Hcl | 11 | $4,416 |
| Aripiprazole | 56 | $2,236 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 68 | $2,211 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 77 | $2,083 |
| Bupropion XlBupropion Hcl | 118 | $2,040 |
| Bupropion Hcl SrBupropion Hcl | 24 | $1,842 |
| Duloxetine Hcl | 69 | $1,504 |
| Methylphenidate Hcl | 14 | $1,223 |
| Haloperidol Decanoate | 12 | $1,195 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $1,178 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $1,097 |
| Methylphenidate Er (La)Methylphenidate Hcl | 13 | $806 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $527 | $34,13824 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $297 | $21,61838 claims |
| Almatica Pharma LLCSertraline Hcl | $16 | $8141 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few psychosomatic medicine providers in Ohioon file to place this against a meaningful peer group, so we don't.
Other psychosomatic medicine in Willoughby
- Kelly SchuderDayton$819
- Patrick SwansonCincinnati$472
- Shiyao WangCleveland$240
- Drew CummingCleveland$224
- Katy LaloneCleveland$26
- Edward KilbaneCleveland$20
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.